Second Opinion: Rebate Rule Would be Revolutionary … For Big Pharma

04-5-2019 Press Release

Nothing in Proposed Rule Guarantees Prices Will Come Down by Full Amount of Rebates On Thursday, U.S. Department of Health and Human Services (HHS) Secretary Alex Azar testified before the U.S. Senate Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies on HHS’ FY2020 budget request.  When asked by Senator […]

“DOSE OF REALITY” Calling Big Pharma’s Bluff On PBMs: Part II

04-5-2019 Press Release

Big Pharma has tried to evade culpability for the crisis of rising prescription drug prices by pointing a finger at pharmacy benefit managers (PBMs).  As the U.S. Senate Committee on Finance prepares to hear from the executives of five PBMs on April 9, it’s time to debunk Big Pharma’s bluffs.  PBMs serve an essential role […]

“DOSE OF REALITY”  Calling Big Pharma’s Bluff On PBMs: Part I

04-4-2019 Press Release

Big Pharma has tried to evade culpability for the crisis of rising prescription drug prices by pointing a finger at pharmacy benefit managers (PBMs).  As the U.S. Senate Committee on Finance prepares to hear from the executives of five PBMs on April 9, it’s time to debunk Big Pharma’s bluffs.  PBMs serve an essential role […]

Bipartisan Advancement Of Key Drug Pricing Bills Signals A Coming Victory For American Patients

04-4-2019 Press Release

For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement after the U.S. House Energy & Commerce Committee advanced a series of bipartisan drug pricing measures, including the CREATES Act, Purple Book Continuity Act of 2019, Orange Book Transparency Act of 2019 and […]

THEY SAID IT! Lawmakers Blast Insulin Price Hikes, Call For Drug Price Action And Question The Rebate Rule

04-3-2019 Press Release

For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] On Tuesday, the U.S. House Committee on Energy and Commerce Subcommittee on Oversight and Investigations held a hearing to discuss with expert witnesses the “Human Impact Of Rising Insulin Costs.”  Members of the subcommittee shared harrowing stories of constituents or loved ones suffering from rising insulin prices […]

CSRxP Encourages House Lawmakers To Advance Bipartisan Drug Pricing Legislation

04-2-2019 Press Release

For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement ahead of a bill markup in the U.S. House Committee on Energy and Commerce on a number of bipartisan drug pricing measures: “We applaud committee leaders in Congress who continue to focus on […]

Insulin Hearing Will Add To Drug Pricing Momentum On Capitol Hill 

04-1-2019 Press Release

CSRxP Commends House Energy & Commerce Committee For Giving Voice To Patients Struggling To Afford Their Medication For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today ahead of a U.S. House  Committee on Energy and Commerce Subcommittee on Oversight and Investigations hearing […]

They Said It! Lawmakers Advance Key Drug Pricing Bills

03-28-2019 Press Release

House Energy & Commerce Members Recommit To Bipartisan Action As Critical Measures Advance For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] On Wednesday, the U.S. House Committee on Energy & Commerce Subcommittee on Health approved several key pieces of legislation aiming to bring down drug prices through increased competition and transparency.  This development marks positive […]

CSRxP Applauds House Lawmakers For Keeping Momentum Going On Key Drug Price Legislation

03-27-2019 Press Release

U.S. House Committee On Energy & Commerce Health Subcommittee Will Markup Several Prescription Drug Bills Wednesday Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement ahead of a bill markup in the U.S. House Committee on Energy & Commerce Subcommittee on Health on a number of crucial, bipartisan drug pricing […]

ICYMI: Drug Prices Are A Matter Of Life And Death

03-21-2019 Press Release

The Hill Lauren Aronson March 21, 2019 https://thehill.com/blogs/congress-blog/435132-drug-prices-are-a-matter-of-life-and-death Few issues are more pressing today than out-of-control drug prices. One in four Americans are unable to afford their medications, and many of them are rationing — or altogether giving up — the very treatments they need to live, sometimes with fatal consequences. As Kathy Sego — […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.